Comment: Serotonin syndrome induced by fluvoxamine and mirtazapine [6]

Annals of Pharmacotherapy

Volumn 35, Issue 12, 2001, Pages 1674-1675

  Isbister, Geoffrey K ^a   Dawson, Andrew H ^b   Whyte, Ian M ^b  

^a NEWCASTLE MATER HOSPITAL   (Australia)

^b UNIVERSITY OF NEWCASTLE   (Australia)

Author keywords

[No Author keywords available]

Indexed keywords

CYPROHEPTADINE; FLUVOXAMINE; MIRTAZAPINE; SEROTONIN; SEROTONIN 2A RECEPTOR; SEROTONIN UPTAKE INHIBITOR;

CASE REPORT; CLINICAL FEATURE; HUMAN; LETTER; PRIORITY JOURNAL; SEROTONIN SYNDROME; WITHDRAWAL SYNDROME;

DRUG INTERACTIONS; FLUVOXAMINE; HISTAMINE H1 ANTAGONISTS; HUMANS; MIANSERIN; SEROTONIN SYNDROME; SEROTONIN UPTAKE INHIBITORS;

EID: 0035659391     PISSN: 10600280     EISSN: None     Source Type: Journal    
DOI: 10.1345/aph.1Z429b     Document Type: Letter

References (8)

1. Serotonin syndrome induced my fluvoxamine and mirtazapme
2. The serotonin syndrome
3. Serotonin syndrome
4. Serotonin syndrome with mirtazapine-fluoxetine combination
5. A comparison of the postmarketing safety of four selective serotonin re-uptake inhibitors including the investigation of symptoms occurring on withdrawal
6. Potent serotonin (5-HT)(2A) receptor antagonists completely prevent the development of hyperthermia in an animal model of the 5-HT syndrome
7. Mirtazapine as treatment for serotonin syndrome
8. Fluvoxamine augmentation increases serum mirtazapine concentrations three- to fourfold